Skip to content

The Influence of Water and Salt Intake on Copeptin Levels During Moderate Alcohol Consumption

The Influence of Water and Salt Intake on Copeptin Levels During Moderate Alcohol Consumption - a Pathophysiological Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03883503
Enrollment
10
Registered
2019-03-21
Start date
2019-02-25
Completion date
2019-04-10
Last updated
2019-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Drinking

Keywords

Copeptin, Salt-water homeostasis

Brief summary

The main interest of this study is to investigate the influence of moderate alcohol consumption (beer) on salt-water homeostasis. Therefore, 10 healthy volunteers will participate in 4 Intervention: * Beer alone * Beer and water * Beer and salt (stock/bouillon) * Water alone During the study day, copeptin, sodium, osmolality and urinary sodium/osmolality will be measured at 6 timepoints.

Interventions

OTHERBeer 5%o

Weight adjusted beer to reach 0.8 blood alcohol content will be given over the time course of 1 hour to the participants

OTHERBeer 8.5%o and water

Weight adjusted beer to reach 0.8 blood alcohol content and water will be given over the time course of 1 hour to the participants

OTHERBeer 8.5%o and stock

Weight adjusted beer to reach 0.8 blood alcohol content and stock will be given over the time course of 1 hour to the participants

OTHERWater

Water equivalent to the calculated volume of beer will be given over the time course of 1 hour to the participants

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy males

Exclusion criteria

* Any acute or chronic illness * History of alcohol dependency * Alcohol consumption \>2 units/day * Active nicotine abuse * Gluten intolerance * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, etc. of the participant * Participation in another study with investigational drug within the 30 days preceding and during the present study * Enrolment of the investigator, his/her family members, employees and other dependent persons * Epileptic seizures within the last year * BMI \<18.5 or ≥25.9kg/m2

Design outcomes

Primary

MeasureTime frameDescription
Difference in copeptin levels between the interventions30 minutes after interventionDifference in copeptin levels (pmol/l) between moderate beer consumption and moderate beer consumption with additional water and sodium (stock/bouillon) intake at timepoint 1.5 hours.

Secondary

MeasureTime frameDescription
Change in plasma sodium levels between the interventions throughout the observation period of 12 hoursObservation period of 12 hoursChange in plasma sodium (mmol/l) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Change in urinary sodium levels between the interventions throughout the observation period of 12 hoursObservation period of 12 hoursChange in urinary sodium (mmol/kg) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Change in plasma osmolality levels between the interventions throughout the observation period of 12 hoursObservation period of 12 hoursChange in plasma osmolality (mmol/kg) levels from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Change in urinary osmolality levels between the interventions throughout the observation period of 12 hoursObservation period of 12 hoursChange in urinary osmolality (mmol/kg) levels from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Change in copeptin levels between the interventions throughout the observation period of 12 hoursObservation period of 12 hoursChange in copeptin Levels (pmol/l) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the Intervention, comparing the interventions
Change in biomarkers involved in the sodium-water homeostasis between the interventions throughout the observation period of 12 hoursObservation period of 12 hoursChange in different biomarkers (e.g., Fibroblast growth factor 21, aldosterone, renin, Interleukin 6, Interleukin 8) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions
Difference in urinary excretion between the interventions throughout the observation period of 12 hoursObservation period of 12 hoursAmount of total urinary excretion (ml) at time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours and 12 hours after start of the intervention, comparing the interventions
Change in blood alcohol content between the interventions throughout the observation period of 12 hoursObservation period of 12 hoursChange in blood alcohol content (°/oo) from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours and 12 hours after start of the intervention, comparing the interventions
Difference in Response to lottery Experiment before and after the interventionDirectly before and 30 minutes after interventionChange in decision making before and after the intervention, comparing the interventions
Change in plasma Glucose levels between the interventions throughout the observation period of 12 hoursObservation period of 12 hoursChange in plasma glucose (mmol/l) levels from baseline to time-point 1 hour, 1.5 hours, 2.5 hours, 4 hours, 12 hours after start of the intervention, comparing the interventions

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026